Glycogen Synthase Kinase 3β: A New Gold Rush in Anti-Alzheimer’s Disease Multitarget Drug Discovery?
Author:
Affiliation:
1. Department of Drug Science and Technology, University of Turin, Via Giuria 9, 10125 Torino, Italy
2. Department for Life Quality Studies, Alma Mater Studiorum-University of Bologna, Corso d’ Augusto 237, 47921 Rimini, Italy
Funder
Universit? di Bologna
Publisher
American Chemical Society (ACS)
Subject
Drug Discovery,Molecular Medicine
Link
http://pubs.acs.org/doi/pdf/10.1021/acs.jmedchem.0c00931
Reference156 articles.
1. A perspective on multi‐target drug discovery and design for complex diseases
2. Harnessing Polypharmacology with Medicinal Chemistry
3. Designed Multiple Ligands. An Emerging Drug Discovery Paradigm
4. Polypharmacology – Foe or Friend?
5. Multi-target-Directed Ligands To Combat Neurodegenerative Diseases
Cited by 57 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Design of Multi-Target drugs of HDACs and other Anti-Alzheimer related Targets: Current strategies and future prospects in Alzheimer’s diseases therapy;Bioorganic Chemistry;2024-10
2. Evolving significance of kinase inhibitors in the management of Alzheimer's disease;European Journal of Pharmacology;2024-09
3. GSK3 inhibition reduces ECM production and prevents age-related macular degeneration–like pathology;JCI Insight;2024-08-08
4. Unlocking hope: GSK-3 inhibitors and Wnt pathway activation in Alzheimer’s therapy;Journal of Drug Targeting;2024-06-11
5. Impact of GSK-3β and CK-1δ on Wnt signaling pathway in alzheimer disease: A dual target approach;Bioorganic Chemistry;2024-06
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3